跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Apretude - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Apretude
Approved
STANDARD
Apretude
Glaxo Operations UK Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a6c9958e9e545c2d
Company
Glaxo Operations UK Limited
Type
Standard
Approval Details
Approval Id
a6c9958e9e545c2d
Drug Approval Philippines Name
Apretude
Product Name
Apretude
Registration Number
DR-XY48834
Brand Name
Apretude
Generic Name
Cabotegravir
Dosage Form
Prolonged-Release Suspension for Intramuscular Injection (Gluteal)
Dosage Strength
200 mg/mL (600 mg/3 mL)
Manufacturer
Glaxo Operations UK Limited
Importer
GlaxoSmithKline Philippines, Inc.
Distributor
GlaxoSmithKline Philippines, Inc.
Company Detail Path
/organization/glaxo-operations-uk-limited
Issuance Date
03 August 2023
Expiry Date
03 August 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a6c9958e9e545c2d
Type
Standard
Back to Philippines FDA Approvals